Interestingly, the cell line with multiple NMD-targeted TP53 transcript isoforms (HCC1599) was among those with the lowest steady-state TP53 gene expression levels across the 40 breast cancer cell lines (Fig. 4c), consistent with the expected effect of NMD on steady-state gene expression level. The gene discussed is TP53; the disease is breast carcinoma.